Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in...

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Major Depressive Disorder (MDD) presents a significant health challenge with limited antidepressant efficacy.
• Current psychiatric classifications may not fully capture the biological underpinnings of depression.
• The National Institute of Mental Health (NIMH) Research Domain Criteria (RDoC) framework proposes a biologically-informed approach to psychiatric disorders.

Purpose of the Study:

• To review and discuss pre-clinical and clinical findings on the effects of antidepressants within specific RDoC paradigms.
• To explore how the RDoC framework can inform our understanding of depressive phenotypes and treatment mechanisms.
• To highlight the potential of RDoC for advancing psychiatric nosology and treatment development.

Main Methods:

• A comprehensive literature search was conducted using PubMed and Google Scholar.
• Data on antidepressant effects on RDoC constructs were systematically retrieved.
• Drug targets were identified via the DrugBank database and analyzed for their relevance to RDoC constructs.

Main Results:

• Studies investigating RDoC paradigms reveal specific effects of antidepressants on neural circuits and behavioral domains relevant to depression.
• Analysis of drug targets suggests potential mechanisms through which antidepressants modulate RDoC constructs.
• Pre-clinical and clinical data support the utility of RDoC in dissecting the heterogeneity of depressive disorders.

Conclusions:

• The RDoC framework provides a valuable tool for understanding the biological basis of depression and antidepressant action.
• Applying RDoC may enable more precise antidepressant selection based on individual symptom profiles.
• RDoC can guide the development of novel therapeutics targeting specific symptom dimensions in depression.